MedTrace Logo

Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active Surveillance

NCT02971085 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 410

Last updated 2019-02-12

No results posted yet for this study

Summary

In this study, the investigators aim to establish the prostate cancer active surveillance prospective cohort in our institution, and finally investigate the 5 year rates of reclassification during active surveillance as the primary endpoint of the current study.

Conditions

Interventions

PROCEDURE

Active surveillance

Active surveillance cohorts are routinely performed the systematic biopsy ≥ 12 cores by TRUS-guided or MR-TRUS fusion according to the protocol based by time path as 1, 2, 4, 7, 10 years and subsequently every 5 years following initial TRUS biopsy.

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Chang Wook Jeong, M.D, Ph.D · Seoul National University Hospital

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2022-01-31
Completion
2027-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02971085 on ClinicalTrials.gov